Last checked at 
Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium, following "extensive" development, optimisation and validation of the kit. Explains that the kit is read-to-use, and designed for the dentification, characterisation and enumeration of epithelial and mesenchymal cancer cells. This includes those undergoing epithelial-to-mesenchymal transition.
Chief Executive Andrew Newland says: "We are now beginning an active promotion of this test to academic and translational research customers. The standardisation and simplification of the cell staining process and the new innovations to retain the harvested cells on the microscope slide will expand the market for Parsortix technology as it will make it easier for customers to adopt the solution in their own laboratories."
Current stock price: 12.00 pence, down 2.8%
12-month change: down 77%
By Holly Beveridge, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
